Developer docs
API playgroundTry for free, no card

Search company profiles

Laidlaw & Company

Full company profile

uuid000s3ql

Namestring
Laidlaw & Company
Legal namestring
Laidlaw & Company (UK) Ltd.
Websiteurl
laidlawltd.com
Company typeenum
Private
Founded yearint
1842
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersNew York, United States
HQ citystring
New York
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices8 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
investment banking services, capital markets advisory, wealth management services, equity research, private placement agent
Industry3 codes
1Private Placement Agents (Reg D/144A)
CodeFSAEALAAPrimaryYes
2Private Equity Fundraising Placement
CodeFSAEALABPrimaryNo
3Sell-Side M&A Advisory
CodeFSAEAGAAPrimaryNo
NAICS code2 codes
  • Investment Banking and Securities Intermediation52315
  • Portfolio Management and Investment Advice523940
SIC code2 codes
  • Security Brokers, Dealers & Flotation Companies6211
  • Investment Advice6282
Product category
Investment Banking
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Capital Markets Services
TypeProfessional Services
Description

Fees from investment banking transactions including private placements, public offerings, follow-on offerings, and advisory services. Revenue generated through placement agent fees, underwriting fees, co-manager fees, and financial advisory commissions.

laidlawltd.com
2Wealth Management
TypeSubscription Recurring
Description

Recurring fee revenue from wealth management services including investment advice, retirement planning, and tax optimization for high-net-worth individuals and institutions.

laidlawltd.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 record
1Laidlaw Venture Partners (LVP)
Description

The venture capital arm of Laidlaw & Company (UK) Ltd., focusing on innovative company investments including portfolio companies such as Amesite, AerWave Medical, and Voltron Therapeutics.

laidlawltd.com
Core offering1 text field

Laidlaw & Company is an independent investment banking boutique and securities broker-dealer that delivers capital raising, M&A advisory, and strategic transaction services to emerging growth and established companies, alongside wealth management advisory for high-net-worth individuals and institutions. It also publishes equity research and operates alternative investment platforms (Lucius Partners, Private Stakes Program). The firm acts as placement agent, co-manager, underwriter, and financial advisor on private placements, public offerings, follow-on offerings, and IPOs, while generating recurring advisory fees through its affiliated Laidlaw Wealth Management and Laidlaw Asset Management entities.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Laidlaw & Company is a financial services firm offering a unified suite of investment banking and capital markets services, wealth management advisory, and equity research. The core offering consists of Investment Banking and Capital Markets (financing solutions, M&A advisory, strategic transactions), supplemented by Wealth Management (personalized financial planning, investment advice, retirement planning), and Equity Research (industry insights and forecasts). Additional offerings include Lucius Partners for alternative investments and the Private Stakes Program for alternative investment vehicles. The company operates as a traditional investment bank, not as a technology or software product company.

Product and service5 records
1Investment Banking and Capital Markets
CategoryInvestment Banking and Capital Markets
Description

Partnering with domestic and international companies to deliver innovative financing solutions and strategic advisory support. The team guides clients through capital raising, M&A transactions, and strategic initiatives using deep market insight, strong execution, and a global network. Services include private placements, public offerings, follow-on offerings, IPOs, placement agent and co-manager roles, and financial advisory commissions.

2Wealth Management
CategoryWealth Management Advisory
Description

Personalized financial strategies including investment advice, retirement planning, and tax optimization to help high-net-worth individuals and institutions achieve long-term financial goals. Includes MoneyGuidePro financial planning tools and ProActive Tax Management strategies via Green Harvest Asset Management.

3Equity Research
CategoryEquity Research
Description

Research from various industries providing detailed insights, recommendations, and forecasts for informed investment decision-making. Supports both institutional clients and the firm's capital markets activity.

4Lucius Partners
CategoryAlternative Investments
Description

A portfolio company and alternative investments platform operating under the Laidlaw umbrella, supporting investments in and capital raising for portfolio companies such as Adaptin Bio.

5Private Stakes Program
CategoryAlternative Investments
Description

Alternative investment vehicles offered as a service to members, clients, and interested parties through a third-party site, operated by the Laidlaw Private Equity arm.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeOthers
Description

Affiliated SEC Registered Investment Advisor providing wealth management services under Laidlaw & Company umbrella.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Healthcare- and technology-focused boutique investment bank and retail broker-dealer. Highly comparable to Laidlaw in targeting emerging-growth issuers with placement-agent and capital-markets services via an internal retail sales force.

TypeDirect peer
Description

Boutique broker-dealer specializing in equity capital markets, placement agent and advisory services for small- and mid-cap issuers. Closely mirrors Laidlaw's placement-agent-led model and emerging-growth client base.

TypeDirect peer
Description

Investment bank focused on small- and mid-cap companies with strong healthcare and consumer coverage. Comparable to Laidlaw in serving emerging-growth issuers through placement, advisory and equity research.

TypeBroad incumbent
Description

Diversified financial services firm spanning investment banking, wealth management, brokerage and asset management. Broader scale and product set than Laidlaw but overlapping capital markets, advisory and wealth management franchises.

TypeDirect peer
Description

Independent boutique investment bank and brokerage providing capital markets, advisory and wealth management services — closely overlapping Laidlaw's positioning as an entrepreneurial, multi-service boutique.

TypeDirect peer
Description

Boutique investment bank focused on emerging-growth and small-cap issuers, providing placement agent, underwriting and advisory services — directly comparable in target issuer profile and deal size.

TypeDirect peer
Description

Mid-market focused boutique investment bank providing equity research, sales, trading and investment banking to growth companies. Overlapping emerging-growth issuer focus and retail distribution channels.

TypeDirect peer
Description

Boutique broker-dealer offering investment banking, institutional sales and trading, equity research and wealth management. Similar size, scope and emerging-growth client base as Laidlaw.

TypeDirect peer
Description

Boutique investment bank and broker-dealer focused on capital raising and advisory for small- and mid-cap issuers. Comparable placement-agent model and emerging-growth client profile to Laidlaw.

TypeDirect peer
Description

Independent investment bank focused on healthcare and life sciences capital markets, placement agent and advisory mandates — directly comparable to Laidlaw's healthcare-IB focus and emerging-growth issuer base.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries5 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment3 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Laidlaw & Company

Investment Bankinglaidlawltd.com

Laidlaw & Company firmographics

Firmographics
Name
Laidlaw & Company
Legal name
Laidlaw & Company (UK) Ltd.
Website
https://laidlawltd.com
Company type
Private
Founded year
1842
Operating status
Operating
Headcount range
101–250 employees
Ownership category
akta.pro rank

Laidlaw & Company industry classification

Industry
Product category
Investment Banking
NAICS
Investment Banking and Securities Intermediation (52315), Portfolio Management and Investment Advice (523940)
SIC
Security Brokers, Dealers & Flotation Companies (6211), Investment Advice (6282)
akta.pro primary industry
Private Placement Agents (Reg D/144A) (FSAEALAA)
akta.pro secondary industries
Private Equity Fundraising Placement (FSAEALAB), Sell-Side M&A Advisory (FSAEAGAA)

Keywords

  • Investment banking services
  • Capital markets advisory
  • Wealth management services
  • Equity research
  • Private placement agent

Where Laidlaw & Company is headquartered

Location

Headquarters

HQ city
New York
HQ country
United States
HQ region
North America

Offices8 records

Markets served

Laidlaw & Company business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Capital Markets Services: Fees from investment banking transactions including private placements, public offerings, follow-on offerings, and advisory services. Revenue generated through placement agent fees, underwriting fees, co-manager fees, and financial advisory commissions.
  2. Wealth Management: Recurring fee revenue from wealth management services including investment advice, retirement planning, and tax optimization for high-net-worth individuals and institutions.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Laidlaw & Company product offering

Product offering

Core offering

Laidlaw & Company is an independent investment banking boutique and securities broker-dealer that delivers capital raising, M&A advisory, and strategic transaction services to emerging growth and established companies, alongside wealth management advisory for high-net-worth individuals and institutions. It also publishes equity research and operates alternative investment platforms (Lucius Partners, Private Stakes Program). The firm acts as placement agent, co-manager, underwriter, and financial advisor on private placements, public offerings, follow-on offerings, and IPOs, while generating recurring advisory fees through its affiliated Laidlaw Wealth Management and Laidlaw Asset Management entities.

Product overview

Laidlaw & Company is a financial services firm offering a unified suite of investment banking and capital markets services, wealth management advisory, and equity research. The core offering consists of Investment Banking and Capital Markets (financing solutions, M&A advisory, strategic transactions), supplemented by Wealth Management (personalized financial planning, investment advice, retirement planning), and Equity Research (industry insights and forecasts). Additional offerings include Lucius Partners for alternative investments and the Private Stakes Program for alternative investment vehicles. The company operates as a traditional investment bank, not as a technology or software product company.

Differentiator

Problem solved

Functional benefit

Brands

  • Laidlaw Venture Partners (LVP): The venture capital arm of Laidlaw & Company (UK) Ltd., focusing on innovative company investments including portfolio companies such as Amesite, AerWave Medical, and Voltron Therapeutics.

Products and services

  • Investment Banking and Capital Markets Partnering with domestic and international companies to deliver innovative financing solutions and strategic advisory support. The team guides clients through capital raising, M&A transactions, and strategic initiatives using deep market insight, strong execution, and a global network. Services include private placements, public offerings, follow-on offerings, IPOs, placement agent and co-manager roles, and financial advisory commissions.
  • Wealth Management Personalized financial strategies including investment advice, retirement planning, and tax optimization to help high-net-worth individuals and institutions achieve long-term financial goals. Includes MoneyGuidePro financial planning tools and ProActive Tax Management strategies via Green Harvest Asset Management.
  • Equity Research Research from various industries providing detailed insights, recommendations, and forecasts for informed investment decision-making. Supports both institutional clients and the firm's capital markets activity.
  • Lucius Partners A portfolio company and alternative investments platform operating under the Laidlaw umbrella, supporting investments in and capital raising for portfolio companies such as Adaptin Bio.
  • Private Stakes Program Alternative investment vehicles offered as a service to members, clients, and interested parties through a third-party site, operated by the Laidlaw Private Equity arm.

Companies that use Laidlaw & Company

Customer profile

Named customers8 records

Segments4 records

Ideal customer profiles3 records

Laidlaw & Company technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Laidlaw & Company partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Laidlaw Wealth ManagementcoreOthersAffiliated SEC Registered Investment Advisor providing wealth management services under Laidlaw & Company umbrella.

Scale indicators4 records

Recent moves7 records

Expansion highlights6 records

Laidlaw & Company competitors and assessment

Company assessment

Direct peers

  • Maxim Group: Healthcare- and technology-focused boutique investment bank and retail broker-dealer. Highly comparable to Laidlaw in targeting emerging-growth issuers with placement-agent and capital-markets services via an internal retail sales force.
  • Aegis Capital Corp. Boutique broker-dealer specializing in equity capital markets, placement agent and advisory services for small- and mid-cap issuers. Closely mirrors Laidlaw's placement-agent-led model and emerging-growth client base.
  • Roth Capital Partners: Investment bank focused on small- and mid-cap companies with strong healthcare and consumer coverage. Comparable to Laidlaw in serving emerging-growth issuers through placement, advisory and equity research.
  • EF Hutton: Independent boutique investment bank and brokerage providing capital markets, advisory and wealth management services — closely overlapping Laidlaw's positioning as an entrepreneurial, multi-service boutique.
  • ThinkEquity (a division of :think): Boutique investment bank focused on emerging-growth and small-cap issuers, providing placement agent, underwriting and advisory services — directly comparable in target issuer profile and deal size.
  • Lake Street Capital Markets: Mid-market focused boutique investment bank providing equity research, sales, trading and investment banking to growth companies. Overlapping emerging-growth issuer focus and retail distribution channels.
  • The Benchmark Company: Boutique broker-dealer offering investment banking, institutional sales and trading, equity research and wealth management. Similar size, scope and emerging-growth client base as Laidlaw.
  • D. Boral Capital: Boutique investment bank and broker-dealer focused on capital raising and advisory for small- and mid-cap issuers. Comparable placement-agent model and emerging-growth client profile to Laidlaw.
  • Wainwright Capital: Independent investment bank focused on healthcare and life sciences capital markets, placement agent and advisory mandates — directly comparable to Laidlaw's healthcare-IB focus and emerging-growth issuer base.

Broad incumbents

  • B. Riley Financial: Diversified financial services firm spanning investment banking, wealth management, brokerage and asset management. Broader scale and product set than Laidlaw but overlapping capital markets, advisory and wealth management franchises.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Laidlaw & Company compliance and trust

Trust signal

Compliance3 records

Laidlaw & Company financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Laidlaw & Company leadership team

Management profile

Number of profiles

Profiles6 records

Laidlaw & Company subsidiaries and ownership

Company hierarchy

Subsidiaries5 records

Laidlaw & Company funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Laidlaw & Company M&A and investment

M&A and investment

M&A

Investments3 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Laidlaw & Company

What does Laidlaw & Company do?

Laidlaw & Company is an independent investment banking boutique and securities broker-dealer that delivers capital raising, M&A advisory, and strategic transaction services to emerging growth and established companies, alongside wealth management advisory for high-net-worth individuals and institutions. It also publishes equity research and operates alternative investment platforms (Lucius Partners, Private Stakes Program). The firm acts as placement agent, co-manager, underwriter, and financial advisor on private placements, public offerings, follow-on offerings, and IPOs, while generating recurring advisory fees through its affiliated Laidlaw Wealth Management and Laidlaw Asset Management entities.

Is Laidlaw & Company a public or private company?

Laidlaw & Company is a private company. It is classified as management employee owned and is currently operating.

When was Laidlaw & Company founded?

Laidlaw & Company was founded in 1842. It employs 101 to 250 people.

Where is Laidlaw & Company based?

Laidlaw & Company is headquartered in New York, United States, in the North America region.

How does Laidlaw & Company make money?

Two revenue lines are on record. Capital Markets Services are the primary driver. The others are wealth Management.

Who are Laidlaw & Company's main competitors?

Direct peers on record are Maxim Group, Aegis Capital Corp., Roth Capital Partners, EF Hutton, ThinkEquity (a division of :think), Lake Street Capital Markets, The Benchmark Company, D. Boral Capital and Wainwright Capital. B. Riley Financial is listed as a broad incumbent.

Does Laidlaw & Company have an API?

No public API is recorded for Laidlaw & Company.

What industry is Laidlaw & Company in?

Laidlaw & Company's product category is Investment Banking. Its primary akta.pro industry code is FSAEALAA, Private Placement Agents (Reg D/144A), with a secondary code of FSAEALAB, Private Equity Fundraising Placement. Its NAICS code is 52315 and its SIC code is 6211.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Investing.comLaidlaw initiates Aeon Biopharma stock coverage with buy rating By Investing.comLaidlaw initiated coverage on AEON Biopharma with a Buy rating and a $1.80 price target, while the stock trades at $0.24. The company is developing ABP-450, a Botox biosimilar, and Laidlaw expects it to advance through the 351(k) path after an FDA meeting. The stock has fallen 78% year-to-date.Investing.comLaidlaw initiates Aeon Biopharma stock coverage with buy rating By Investing.comLaidlaw initiated coverage on AEON Biopharma with a Buy rating and a $1.80 price target, while the stock trades at $0.24. The company is developing ABP-450, a Botox biosimilar, and Laidlaw expects it to advance through the 351(k) regulatory path after an FDA meeting.Pulse 2.0Vêtir: $5.5 Million Series A Raised At $150 Million Valuation For AI Luxury Fashion PlatformVêtir, an AI-powered luxury fashion platform, announced the first close of its Series A financing, raising $5.5 million at a $150 million valuation, led by a consortium including Laidlaw & Company. The company reported strong growth metrics including 200% month-over-month organic user expansion, 3,500%+ growth in B2B clients, and 9x year-over-year revenue growth. Vêtir stated proceeds will be used to accelerate its personalization engine development, expand internationally, and deepen integrations with enterprise luxury fashion partners.citybizLuxury Wardrobe Management Startup Vetir Secures $5.5M Series ANew York-based Vêtir, an AI-powered luxury wardrobe management startup, has completed the first close of its Series A funding, raising $5.5 million at a $150 million valuation. The round was led by a consortium of investors including Laidlaw & Company, with the capital earmarked for expansion into the United Kingdom and Europe and to further develop its technology platform. The company reported strong growth metrics over the past year, including 200% month-over-month user growth and 9x year-over-year revenue expansion.Venture Capital Access OnlineVêtir Secures $5.5M Series A at $150M Valuation; Opens Limited Strategic Allocation to Build Category-Defining AI Platform for Luxury FashionVêtir raised $5.5 million in a Series A at a $150 million valuation, led by a consortium including Laidlaw & Company. The AI luxury wardrobe platform reported 200% month-over-month organic user growth, 3,500%+ B2B client growth, and 9x year-over-year revenue growth. It plans to accelerate its personalization engine and expand globally.BusinessoffashionExclusive: Vêtir Valued at $150 Million in New Funding RoundVêtir, an AI-powered styling and shopping app, raised $5.5 million in a Series A round that valued it at $150 million. The round was led by private family offices and luxury retail and tech investors including Laidlaw & Company. The funding will be used to build out Vêtir's data capabilities and expand into new markets such as the UK and Europe.SecSEC FORM DAdaptin Bio, Inc., a biotechnology company headquartered in Charlotte, North Carolina, filed a Form D notice with the SEC reporting an exempt equity offering under Rule 506(b) with a total offering amount of $4,000,000. The filing, dated March 18, 2026, as an amendment to the original notice, indicates $1,652,000 has already been sold to 13 investors, with $2,348,000 remaining. Sales commissions of $198,240 are being paid to placement agent Laidlaw & Company (UK) Ltd., with the first sale recorded on December 22, 2025.SecSEC FORM DAdaptin Bio, Inc., a Delaware-incorporated biotechnology company headquartered in Charlotte, North Carolina, filed a Form D with the SEC disclosing an exempt securities offering under Rule 506(b) with a total offering amount of $4,000,000. As of the first sale on December 22, 2025, the company had sold $1,297,000 in securities to 10 investors, with $2,703,000 remaining to be sold. The filing, signed by President and CEO Michael J. Roberts on February 19, 2026, also disclosed $155,640 in sales commissions paid to placement agent Laidlaw & Company (UK) Ltd.NasuspharmaNasus Pharma Announces Closing of $15.0 Million Private PlacementNasus Pharma Ltd. announced the closing of a $15.0 million private placement, selling 2,695,425 ordinary shares and accompanying warrants at $5.565 per share, with warrants exercisable at $6.53 per share expiring two years from issuance. Citizens Capital Markets served as lead placement agent and Laidlaw & Company (UK) Ltd. as co-placement agent for the transaction. The company intends to use proceeds to advance its NS002 intranasal epinephrine product candidate through pivotal clinical development and for working capital purposes.YahooNasus Pharma Announces Closing of $15.0 Million Private PlacementNasus Pharma, a clinical-stage pharmaceutical company focused on innovative intranasal products, announced the closing of a private placement of ordinary shares and warrants for aggregate gross proceeds of approximately $15.0 million, before deducting placement agent fees and offering expenses. Citizens Capital Markets acted as lead placement agent and Laidlaw & Company (UK) Ltd. acted as co-placement agent in connection with the transaction. The proceeds are expected to fund the advancement of NS002, the company's powder-based intranasal epinephrine product candidate, toward a pivotal study and New Drug Application submission.